Dobrodeeva, V.S.; Shnayder, N.A.; Novitsky, M.A.; Asadullin, A.R.; Vaiman, E.E.; Petrova, M.M.; Limankin, O.V.; Neznanov, N.G.; Garganeeva, N.P.; Nasyrova, R.F.
Association of a Single-Nucleotide Variant rs11100494 of the NPY5R Gene with Antipsychotic-Induced Metabolic Disorders. Pharmaceutics 2022, 14, 222.
https://doi.org/10.3390/pharmaceutics14020222
AMA Style
Dobrodeeva VS, Shnayder NA, Novitsky MA, Asadullin AR, Vaiman EE, Petrova MM, Limankin OV, Neznanov NG, Garganeeva NP, Nasyrova RF.
Association of a Single-Nucleotide Variant rs11100494 of the NPY5R Gene with Antipsychotic-Induced Metabolic Disorders. Pharmaceutics. 2022; 14(2):222.
https://doi.org/10.3390/pharmaceutics14020222
Chicago/Turabian Style
Dobrodeeva, Vera S., Natalia A. Shnayder, Maxim A. Novitsky, Azat R. Asadullin, Elena E. Vaiman, Marina M. Petrova, Oleg V. Limankin, Nikolay G. Neznanov, Natalia P. Garganeeva, and Regina F. Nasyrova.
2022. "Association of a Single-Nucleotide Variant rs11100494 of the NPY5R Gene with Antipsychotic-Induced Metabolic Disorders" Pharmaceutics 14, no. 2: 222.
https://doi.org/10.3390/pharmaceutics14020222
APA Style
Dobrodeeva, V. S., Shnayder, N. A., Novitsky, M. A., Asadullin, A. R., Vaiman, E. E., Petrova, M. M., Limankin, O. V., Neznanov, N. G., Garganeeva, N. P., & Nasyrova, R. F.
(2022). Association of a Single-Nucleotide Variant rs11100494 of the NPY5R Gene with Antipsychotic-Induced Metabolic Disorders. Pharmaceutics, 14(2), 222.
https://doi.org/10.3390/pharmaceutics14020222
